Mirum Pharmaceuticals (MIRM) Free Cash Flow (2019 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Free Cash Flow of -$229.4 million for Q1 2026, down 11359.89% year-over-year from N/an in Q1 2025, and down 4296.58% quarter-over-quarter from $5.5 million in Q4 2025.
Powered by 
Analysis
Mirum Pharmaceuticals (MIRM) Free Cash Flow (2019 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Free Cash Flow history runs 8 years deep, the most recent figure standing at -$229.4 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 11359.89% year-over-year to -$229.4 million; the TTM figure through Mar 2026 stood at -$172.6 million (down 2092.81% YoY), while the FY2025 annual figure was $54.9 million, up 488.01% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$229.4 million, down from $5.5 million in the prior quarter.
- The five-year high for Free Cash Flow was $39.5 million in Q3 2025, with the low at -$229.4 million in Q1 2026.
- The 5-year median for Free Cash Flow is -$16.6 million (2023), against an average of -$21.0 million.
- The sharpest annual moves came in 2025 and 2026: Free Cash Flow surged 938.5% in 2025, then sank 11359.89% in 2026.
- Mirum Pharmaceuticals' Free Cash Flow stood at -$34.5 million in 2022, then jumped by 51.85% to -$16.6 million in 2023, then soared by 69.38% to -$5.1 million in 2024, then surged by 207.45% to $5.5 million in 2025, then tumbled by 4296.58% to -$229.4 million in 2026.
- Business Quant data shows MIRM's Free Cash Flow at -$229.4 million in Q1 2026, $5.5 million in Q4 2025, and $39.5 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -563.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -389.61 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 437.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 292.04 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 477.44 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Mirum Pharmaceuticals | 6.40 Bn | 5.96 Bn | 145.90 Mn | -44.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -44.28 Mn |
| Mar 31, 2026 | -229.43 Mn |
| Dec 31, 2025 | 5.47 Mn |
| Sep 30, 2025 | 39.49 Mn |
| Jun 30, 2025 | 11.91 Mn |
| Mar 31, 2025 | -2.00 Mn |
| Dec 31, 2024 | -5.09 Mn |
| Sep 30, 2024 | 3.80 Mn |
| Jun 30, 2024 | -4.58 Mn |
| Mar 31, 2024 | 15.20 Mn |
| Dec 31, 2023 | -16.62 Mn |
| Sep 30, 2023 | -18.22 Mn |
| Jun 30, 2023 | -17.40 Mn |
| Mar 31, 2023 | -18.82 Mn |
| Dec 31, 2022 | -34.51 Mn |
| Sep 30, 2022 | -26.04 Mn |
| Jun 30, 2022 | -20.19 Mn |
| Mar 31, 2022 | -39.67 Mn |
| Dec 31, 2021 | -33.15 Mn |
| Sep 30, 2021 | -34.22 Mn |